glp-1 and parkinson's disease Drugs Disease: New Clues in Neurodegeneration GLP-1 Signalling as a Therapeutic

Huang, L., Zalkikar, J

Theres less competitive force on the feather side of the mountain, Bernstein said

Pyroglutamate acidosis 2023

Materials and methods: Using electronic health record and genetic data from 51,108 British Pakistani and Bangladeshi individuals with T2D (n = 11,673) and GDM (n = 1,965) in the Genes & Health study, we explored associations between pPS, T2D, GDM, diabetes complications, and treatment response using sex- and ancestry-adjusted multivariable regression and Cox proportional-hazards models

6 "Patients with diabetes often struggle to manage their disease, and often have concerns when faced with the need to add an injectable medicine to their treatment regimen," said Dr

Journal of Practical Training of Medicine 2007;23:1325-1326